FILUCIMOD ALFA
UNII 2HQK7S7NVH

Substance Identification & Data

This profile provides standardized clinical and technical data for Filucimod Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2HQK7S7NVH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3082438-06-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2HQK7S7NVH

CAS Registry Number

3082438-06-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

FILUCIMOD ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14126

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Filucimod Alfa

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Filucimod Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

Filucimod Alfa

Immunoglobulin G1 [32-alanine], (human γ1-chain C region C-terminal fragment NVG-2089), dimer

filucimod alfa [INN]

human immunoglobulin G1 (IgG1) Fc fragment (hinge-CH2-CH3-CHS domains) [Homo sapiens IGHG1*01 (hinge (7-21), CH2 F23>A(22-131), CH3 (132-236), CHS (237-238)) (7-238)], with 1KVDKKV6>added for stability, dimer (11-11', 17-17', 20-20')-trisdisulfide, produced in Chinese hamster ovary (CHO) cells in an engineered CHO K1 cell line lacking glutamine synthetase (GS-KO) and coexpressing beta-galactoside alpha-2,6-sialyltransferase 1 (ST6GAL1) and beta-1,4-galactosyltran

External Clinical & Regulatory Resources

Previous UNII2HQH877HUN

Next UNII2HR315841W